Hankil Yoon

Insider Reports History

Location
2 East Broad Street, 2 Nd Floor, Hopewell, NJ
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hankil Yoon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apimeds Pharmaceuticals US, Inc. Director Stock Option (right to buy) 10K Nov 11, 2025 Direct

Insider Reports Filed by Hankil Yoon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APUS Apimeds Pharmaceuticals US, Inc. Nov 11, 2025 1 $0 4 Nov 13, 2025 Director
APUS Apimeds Pharmaceuticals US, Inc. Oct 15, 2025 1 $0 4 Oct 17, 2025 Director
APUS Apimeds Pharmaceuticals US, Inc. May 16, 2025 1 $0 4 May 20, 2025 Director
APUS Apimeds Pharmaceuticals US, Inc. Mar 4, 2025 0 $0 3 May 8, 2025 Director